Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021

SELL
$93.66 - $139.27 $1,873 - $2,785
-20 Reduced 28.57%
50 $6,000
Q4 2020

Feb 05, 2021

BUY
$99.61 - $142.12 $1,992 - $2,842
20 Added 40.0%
70 $9,000
Q1 2019

Apr 23, 2019

SELL
$61.98 - $96.5 $12,396 - $19,300
-200 Reduced 80.0%
50 $4,000
Q3 2018

Oct 16, 2018

BUY
$48.29 - $80.6 $9,658 - $16,119
200 Added 400.0%
250 $19,000
Q3 2017

Oct 27, 2017

BUY
$37.05 - $47.12 $1,852 - $2,356
50
50 $2,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Hudock, Inc. Portfolio

Follow Hudock, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hudock, Inc. with notifications on news.